- Home
- Equipment
- usa massachusetts
- stents pushers application system
Show results for
Refine by
Applications
- Software Solutions for Patient Groups
- Software Solutions for Researchers
- Software Solutions for Sponsors
- BrightInsight Solutions for Biopharma
- Software Solution for Patient or Caregiver
- Software Solution for Healthcare Provider
- Software Solution for Pharma
- Software Solution for Payer
- NantHealth healthcare solutions for hospitals and health systems sector
- NantHealth healthcare solutions for practices and medical groups sector
- Remote Patient Monitoring Solution for Remote Patient Monitoring
- Remote Patient Monitoring Solution for Revenue Cycle Management
- Remote Patient Monitoring Solution for EHR Integration
- Supply Solutions for Early-Phase Planning
- IGX Platform Software for Immuno-Oncology
- IGX Platform Software for Cancer Vaccines
- IGX Platform Software for Autoimmunity
- IGX Platform Software for Infectious Diseases
- Software Solutions for Deep Mutational Scanning & Selection
- Software Solutions for COVID-19
- Software Tools for Pharmaceuticals & Specialty Chemicals
Microport Stents Pushers Application System Equipment & Supplies In In Usa Massachusetts
4 equipment items found
Manufactured by:MicroPort Scientific Corporation based inShanghai, CHINA
Extraordinary Deliverability. Ultra Low Profile. Target Eluting Technology of ...
Manufactured by:MicroPort Scientific Corporation based inShanghai, CHINA
Immediate Occlusion, Effective Exclusion. Willis® Intracranial Stent Graft system is a stent graft solution for the treatment of intracranial aneurysms. The immediate blood flow reconstruction can effectively isolate the blood flow between the aneurysm and the parent artery, while still keeping the blood flow to the parent artery unobstructed. This way, the hemodynamics of the lesion area is ...
Manufactured by:MicroPort Scientific Corporation based inShanghai, CHINA
CoCr Stent Platform. Reliable durable polymer-Styrene Butylenes Styrene. Uniform sine wave design provides uniform support strength and ...
Manufactured by:MicroPort Scientific Corporation based inShanghai, CHINA
TARGET All Comers Trial: 1,656 Patients from 20 sites in Europe. 1:1 RCT Real World open-label, non-inferiority trial Primary endpoint: TLF @12 months. Confirms that the Firehawk®, a low dose sirolimus eluting biodegradable polymer DES, is safe. and effective across a broad spectrum of patient and lesion complexity. ...